Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Addition of Efavirenz to Induce CARD8-mediated Reduction of Persistent Nonsuppressible HIV Viremia in People With High Adherence to ART.

NCT06823596 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT06823596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Addition of Efavirenz to Induce CARD8-mediated Reduction of Persistent Nonsuppressible HIV Viremia in People With High Adherence to ART.
Lead sponsor
University of Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
January 14, 2025
Completion date
November 15, 2028
Enrollment
26 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv